tirzepatide nda Compounded FDA says shortage of GLP-1

Learn which features matter most, from macro tracking to portion control, to support your weight loss journey.

Tirzepatide has emerged as a powerful weight loss option for non-diabetics, with clinical trials demonstrating sustained results and a manageable safety profile when dosed appropriately by a healthcare provider

Insurance coverage for Zepbound remains limited for weight loss, leaving many patients searching for accessible alternatives

Following the initial top-line readout in August which showed a statistically significant, 20% relative risk reduction in MACE-3 cardiovascular events the veil has finally been lifted from the landmark SELECT cardiovascular outcomes trial

Wondering which weight loss medication is right for you

Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently a pressing public health issue associated with adverse outcomes such as cirrhosis, malignancy, transplantation, and mortality